BridgeMD
New treatment option for Hemorrhoids
Official title Trans-radial Superior Rectal Artery Embolisation for Haemorrhoids
ClinicalTrials.gov ID: NCT06175325
What this study is testing
- What it's testing
- Endovascular embolisation is already a common procedure for bleeding haemorrhoids in the acute setting, where surgical options are not possible or have been exhausted. This pilot study aims to add to the small body of evidence that transarterial embolisation of symptomatic haemorrhoids is also safe and effective in the elective setting, providing a good alternative to conventional surgical management.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients eligible for the study must comply with all of the following prior to enrolment:
- Patients with grade II-IV haemorrhoid disease with re-current or active bleeding
- Patients with (i) who do not wish to undergo surgery for their symptoms
- Patients with (i) despite recent surgery
- Patients willing and able to give fully informed consent
You likely can't join if
- Patients who are not otherwise fit for surgery
- Patients with significant ano-rectal comorbidities (cancer, fistula, abscesses)
- Patient who are unable to sign the informed consent form.
- Patients who are pregnant (completed as part of standard IRMER protocol)
- Patients with history of significant colorectal disease or previous colectomy.
- Patients with history of an allergic reaction to x-ray contrast
See the full eligibility criteria
- Patients eligible for the study must comply with all of the following prior to enrolment:
- Patients with grade II-IV haemorrhoid disease with re-current or active bleeding
- Patients with (i) who do not wish to undergo surgery for their symptoms
- Patients with (i) despite recent surgery
- Patients willing and able to give fully informed consent
- Patients aged ≥18 years
- Patients who are not otherwise fit for surgery
- Patients with significant ano-rectal comorbidities (cancer, fistula, abscesses)
- Patient who are unable to sign the informed consent form.
- Patients who are pregnant (completed as part of standard IRMER protocol)
- Patients with history of significant colorectal disease or previous colectomy.
- Patients with history of an allergic reaction to x-ray contrast
- Patients who are currently involved in research
The study team makes the final eligibility decision.
Where it's taking place
- Stoke-on-Trent, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stoke-on-Trent, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.